glp-1 maintenance dose after weight loss Compare Options | Ozempic v Mounjaro | WeightWatchers Monthly GLP-1 for Weight Maintenance

The recently published SURPASS-2 has been conducted in order to compare the efficacy and safety of the three doses of tirzepatide with the GLP-1 agonist semaglutide at an injectable dose of 1 mg in patients with T2DM inadequately controlled with metformin monotherapy

When GLP-1 drugs are started or stopped without proper clinical assessment, follow-up and lifestyle support, patients may experience rebound weight gain and other health complications

Be the first to share your experience

There are currently no approved treatments for kidney transplant recipients facing BKPyV infection." To view or add a comment, sign in Roche has introduced the cobas HDV test for use on the cobas 5800, 6800, and 8800 systems, a diagnostic tool for the detection and quantification of hepatitis D virus RNA